close search

Indications of immune protection from hepatitis C infection.

Aitken CK, Bowden S, Hellard M, Crofts N

VIEW FULL ARTICLE
  • Journal Journal of urban health : bulletin of the New York Academy of Medicine

  • Published 17 Aug 2004

  • Volume 81

  • ISSUE 1

  • Pagination 58-60

  • DOI 10.1093/jurban/jth088

Abstract

Hepatitis C affects many millions of people worldwide and is at very high prevalence among people who inject drugs. In our study of hepatitis C virus (HCV) in the social networks of injecting drug users (IDUs), five IDUs with injecting careers of 9 years or more were HCV antibody and RNA negative. All injected frequently with HCV RNA-positive IDUs, and two had recently injected with the syringe of an RNA-positive IDU. Our data suggest the existence of immune protection from HCV infection.